DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

Illumina (NASDAQ: ILMN)

135.37 -0.68 (-0.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ILMN $135.37 -0.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $135.01
Previous Close $136.05
Daily Range $130.37 - $137.23
52-Week Range $130.00 - $242.37
Market Cap $19.8B
P/E Ratio 40.98
Dividend (Yield) $0.00 (0.0%)
Volume 1,913,817
Average Daily Volume 1,830,680
Current FY EPS $3.30




Drug Makers

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website:

News & Commentary

Qiagen NV Is Prepping for Growth

With the decline in HPV test sales mostly behind it, the lab-test maker is looking for a stronger 2016 and beyond.

Add Up The Pieces: SPYG Could Be Worth $113

Nasdaq 100 Movers: ILMN, FAST

Benzinga's Top Downgrades

Analysts' Actions -- GoPro, Boston Beer, Match, Whirlpool and More

Illumina's Earnings Miss, Revenues Beat; MiSeq Orders High

Illumina Inc. Reports Q4 Earnings Decline

Higher costs of revenue hurt the genomic sequencing company in the fourth quarter.

3 Stocks Pulling The Drugs Industry Downward

Nasdaq 100 Movers: ILMN, STX

Illumina (ILMN) Earnings Report: Q4 2015 Conference Call Transcript

See More ILMN News...

ILMN's Top Competitors

ILMN $135.37 (-0.50%)
Current stock: ILMN
TMO $121.94 (-1.01%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
QGEN $20.49 (-2.66%)
Current stock: QGEN